Efficacy and Tolerability of Zolmitriptan Nasal Spray

NCT00617747 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2114

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Zolmitriptan
DRUG: Placebo

Sponsor

AstraZeneca